 BOSTON, MA ACCESSWIRE October 26, 2022 Pieris Pharmaceuticals, Inc. NASDAQ:PIRS , a clinical-stage biotechnology company advancing novel biotherapeutics through its proprietary Anticalin technology platform for respiratory diseases, cancer and other indications, today announced that it will host a third quarter 2022 investor call on Wednesday, November 2, 2022 at 8:00 AM EDT to discuss financial results and provide a corporate update. To access the call, participants may dial 888 645-4404 Toll Free US Canada or 862 298-0702 International at least five minutes prior to the start of the call. 